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Short introduction
Actinomycetes harbor a wealth of natural products with structural complexity and diverse biological activities (Abdelmohsen et al., 2014a; Nett et al., 2009; Li and Vederas, 2009; Abdelmohsen et al., 2015) . Genomic sequence data have revealed the presence of putatively silent biosynthetic gene clusters in the genomes of actinomycetes that encode for secondary metabolites, which are not seen under standard fermentation conditions (Cimermancic et al., 2014) . The actinomycete isolates Streptomyces sp. SBT349, Nonomureae sp. SBT364, and Norcardiopsis sp. SBT366 were cultivated from marine sponges Sarcotragus spinosulus, Sarcotragus foetidus, and Chondrilla nucula, respectively. The strains have been deposited in the German Collection of Microorganisms and Cell Cultures (DSMZ) with accession numbers DSM 100667 (SBT349), DSM 100666 (SBT364), and DSM 100668 (SBT366). The sponges were collected by SCUBA diving at 5-7m depth from offshore Pollonia, Milos, Greece (N36.76612°; E24.51530°) in May 2013 under the umbrella of the EU-FP7 project entitled "SeaBioTech: From sea-bed to test-bed: harvesting the potential of marine biodiversity for industrial biotechnology" that aims to create innovative marine biodiscovery pipelines. Members of the genera Streptomyces and Nocardiopsis are widespread in terrestrial environments, including soil and plants and have also been isolated from the marine environment, i.e., from marine sponges (Abdelmohsen et al., 2010; Vicente et al., 2013; Abdelmohsen et al., 2014b; Eltamany et al., 2014) . We report here, to our knowledge for the first time, the isolation of members of the genus Nonomureae from marine environment. Among the 50 actinomycetes cultivated from the Milos collection, the organic extracts of isolates SBT349, SBT364, and SBT366 exhibited rich HPLCpeak profiles as well as diverse bioactivities including antioxidant, antitrypanosomal and anticancer, respectively (Cheng et al., 2015) . These isolates were selected based on their HPLC-peak richness and bioactivity profile for further genomic sequencing.
Data description
Genomic DNA of the actinomycetes was extracted and prepared as described (Harjes et al., 2014) . 250 bp paired-end sequencing was performed on a MiSeq benchtop sequencer (Illumina). Obtained reads were adapter trimmed as well as quality and length filtered using Trimmomatic 0.32 (Bolger et al., 2014) . Assembly was performed using SPAdes 3.1.1 (Bankevich et al., 2012) and calculated contigs were manually filtered due to low coverage. Remaining contigs were extended and merged wherever possible using SSPACE 3.0. (Boetzer et al., 2011) . The RAST webserver was used for annotation (Aziz et al., 2008) (Table 1) .
The draft genomes were mined using antiSMASH 3.0 ("Antibiotic and Secondary Metabolites Analysis Shell") (Weber et al., 2015) and NapDos ("The natural product domain seeker") (Ziemert et al., 2012) . Among the three genomes sequenced, Streptomyces sp. SBT349 displayed the most diverse antiSMASH read-out. A total of 108 potential secondary metabolite gene clusters were predicted, encoding for 23 type I polyketide synthases (PKS), 11 non-ribosomal peptide synthetases (NRPSs), 2 terpenes, 21 saccharides, 3 siderophores, 3 lantipeptides, 1 butyrolactone, 1 bacteriocin, 1 phenazine, 1 ladderane, and 1 linaridin, as well as 26 unidentified putative clusters (Table 2) . antiSMASH results showed that strain Streptomyces sp. SBT349 has the highest potential in comparison to the two other strains to produce type I polyketides and non-ribosomal peptides which are the major classes of pharmacologically active natural products as well as the potential to produce linaridins which are post-translationally modified peptides with interesting biological properties. Furthermore, NaPDoS predicted the presence of natural products such as nystatin, rapamycin, rifamycin, epothilone, and tetronomycin. For Nonomureae sp. SBT364, NaPDoS predicted the presence of gene clusters encoding for rifamycin, avermectin, avilamycin, concanamycin, and tetronomycin. Thirdly, for Nocardiopsis sp. SBT366, gene clusters encoding for pikromycin, alnumycin, amphotericin, and mycinamicin were predicted. In summary, sequencing genomes of three sponge-associated actinomycete Streptomyces sp. SBT349, Nonomureae sp. SBT364, and Nocardiopsis sp. SBT366 provided new insights into the genomic underpinnings of actinomycete secondary metabolism, which may deliver novel chemical scaffolds with interesting biological activities for the drug discovery pipeline. Future work will include bioassay-guided isolation of the bioactive natural products based on the genomic information gained from this study. Minimum Information about the Genome Sequence (MIGS) is provided in Table 3 .
Nucleotide sequence accession number
The whole-genome shotgun (WGS) projects were deposited at GenBank under the Bioproject ID PRJNA280805 with the accession numbers LAVK00000000, LAVL00000000 and LAVM00000000. The versions described here are LAVK01000000, LAVL01000000 and LAVM01000000. 
